Stanford University · Biomedical EngineeringMicrobiome ImmunoInnovations Lab
Michael Andrew Fischbach · Stanford, California
Research Focus
Dr. Michael Fischbach's lab at Stanford University focuses on harnessing the power of the human microbiome to create innovative vaccines. By engineering certain beneficial bacteria to target diseases like cancer and autoimmune conditions, the lab aims to develop solutions that are effective, durable, and easy to distribute, particularly in low-resource settings. This research combines cutting-edge technologies from immunology and microbiology to redefine how vaccines can be designed and applied.
commensal vaccinesimmune responsemicrobiomecancer immunotherapyautoimmune diseases
Research Aims
4AIM 01Identify bacterial strains that can modulate immune responses
AIM 02Optimize T cell induction for cancer treatment
AIM 03Enhance B cell responses to prevent infections
AIM 04Redirect immune responses to target autoimmune diseases
Skills the Lab Values
bacterial engineeringimmunological assayscell cultureflow cytometryanimal models
Output against the department
Publications330top 28% of dept.165th of 595
this lab
most publishedleast published
Citations59ktop 3% of dept.15th of 595
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.